195 related articles for article (PubMed ID: 31911305)
1. Design, synthesis and SAR study of 3rd-generation taxoids bearing 3-CH
Wang C; Wang X; Sun Y; Taouil AK; Yan S; Botchkina GI; Ojima I
Bioorg Chem; 2020 Jan; 95():103523. PubMed ID: 31911305
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and SAR study of Fluorine-containing 3rd-generation taxoids.
Wang C; Chen L; Sun Y; Guo W; Taouil AK; Ojima I
Bioorg Chem; 2022 Feb; 119():105578. PubMed ID: 34979464
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of new-generation taxoids.
Ojima I; Chen J; Sun L; Borella CP; Wang T; Miller ML; Lin S; Geng X; Kuznetsova L; Qu C; Gallager D; Zhao X; Zanardi I; Xia S; Horwitz SB; Mallen-St Clair J; Guerriero JL; Bar-Sagi D; Veith JM; Pera P; Bernacki RJ
J Med Chem; 2008 Jun; 51(11):3203-21. PubMed ID: 18465846
[TBL] [Abstract][Full Text] [Related]
4. Syntheses and Structure-Activity Relationships of Novel 3'-Difluoromethyl and 3'-Trifluoromethyl-Taxoids.
Kuznetsova LV; Pepe A; Ungureanu IM; Pera P; Bernacki RJ; Ojima I
J Fluor Chem; 2008; 129(9):817-828. PubMed ID: 19448839
[TBL] [Abstract][Full Text] [Related]
5. Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluation.
He Z; Schulz A; Wan X; Seitz J; Bludau H; Alakhova DY; Darr DB; Perou CM; Jordan R; Ojima I; Kabanov AV; Luxenhofer R
J Control Release; 2015 Jun; 208():67-75. PubMed ID: 25725361
[TBL] [Abstract][Full Text] [Related]
6. Syntheses and biological activity of C-3'-difluoromethyl-taxoids.
Ojima I; Lin S; Slater JC; Wang T; Pera P; Bernacki RJ; Ferlini C; Scambia G
Bioorg Med Chem; 2000 Jul; 8(7):1619-28. PubMed ID: 10976509
[TBL] [Abstract][Full Text] [Related]
7. Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells.
Ojima I; Slater JC; Michaud E; Kuduk SD; Bounaud PY; Vrignaud P; Bissery MC; Veith JM; Pera P; Bernacki RJ
J Med Chem; 1996 Sep; 39(20):3889-96. PubMed ID: 8831755
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the chemistry and biology of new generation taxoids.
Ojima I; Das M
J Nat Prod; 2009 Mar; 72(3):554-65. PubMed ID: 19239240
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biological Evaluation of Novel 3'-Difluorovinyl Taxoids.
Kuznetsova L; Sun L; Chen J; Zhao X; Seitz J; Das M; Li Y; Veith JM; Pera P; Bernacki RJ; Xia S; Horwitz SB; Ojima I
J Fluor Chem; 2012 Nov; 143():177-188. PubMed ID: 23139432
[TBL] [Abstract][Full Text] [Related]
10. Syntheses and structure-activity relationships of taxoids derived from 14 beta-hydroxy-10-deacetylbaccatin III.
Ojima I; Slater JC; Kuduk SD; Takeuchi CS; Gimi RH; Sun CM; Park YH; Pera P; Veith JM; Bernacki RJ
J Med Chem; 1997 Jan; 40(3):267-78. PubMed ID: 9022793
[TBL] [Abstract][Full Text] [Related]
11. Modification of C-seco taxoids through ring tethering and substituent replacement leading to effective agents against tumor drug resistance mediated by βIII-Tubulin and P-glycoprotein (P-gp) overexpressions.
Tang Y; Rodríguez-Salarichs J; Zhao Y; Cai P; Estévez-Gallego J; Balaguer-Pérez F; Redondo Horcajo M; Lucena-Agell D; Barasoain I; Díaz JF; Fang WS
Eur J Med Chem; 2017 Sep; 137():488-503. PubMed ID: 28624703
[TBL] [Abstract][Full Text] [Related]
12. Overcoming multidrug resistance in taxane chemotherapy.
Geney R; Ungureanu lM; Li D; Ojima I
Clin Chem Lab Med; 2002 Sep; 40(9):918-25. PubMed ID: 12435109
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and structure-activity relationships of novel taxane-based multidrug resistance reversal agents.
Ojima I; Borella CP; Wu X; Bounaud PY; Oderda CF; Sturm M; Miller ML; Chakravarty S; Chen J; Huang Q; Pera P; Brooks TA; Baer MR; Bernacki RJ
J Med Chem; 2005 Mar; 48(6):2218-28. PubMed ID: 15771464
[TBL] [Abstract][Full Text] [Related]
14. Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery.
Ojima I; Wang X; Jing Y; Wang C
J Nat Prod; 2018 Mar; 81(3):703-721. PubMed ID: 29468872
[TBL] [Abstract][Full Text] [Related]
15. Chemistry and chemical biology of taxane anticancer agents.
Miller ML; Ojima I
Chem Rec; 2001; 1(3):195-211. PubMed ID: 11895119
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological activity of novel C2-C3' N-Linked macrocyclic taxoids.
Ojima I; Geng X; Lin S; Pera P; Bernacki RJ
Bioorg Med Chem Lett; 2002 Feb; 12(3):349-52. PubMed ID: 11814794
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the new generation taxane anticancer agents.
Geney R; Chen J; Ojima I
Med Chem; 2005 Mar; 1(2):125-39. PubMed ID: 16787308
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of new taxoids derived from 2-deacetoxytaxinine J.
Botta M; Armaroli S; Castagnolo D; Fontana G; Pera P; Bombardelli E
Bioorg Med Chem Lett; 2007 Mar; 17(6):1579-83. PubMed ID: 17254787
[TBL] [Abstract][Full Text] [Related]
19. A new taxoid from a callus culture of Taxus cuspidata as an MDR reversal agent.
Dai J; Bai J; Hasegawa T; Nishizawa S; Sakai J; Oka S; Kiuchi M; Hirose K; Tomida A; Tsuruo T; Li M; Ando M
Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):306-9. PubMed ID: 16508182
[TBL] [Abstract][Full Text] [Related]
20. Syntheses and evaluation of novel fatty acid-second-generation taxoid conjugates as promising anticancer agents.
Kuznetsova L; Chen J; Sun L; Wu X; Pepe A; Veith JM; Pera P; Bernacki RJ; Ojima I
Bioorg Med Chem Lett; 2006 Feb; 16(4):974-7. PubMed ID: 16298526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
